Biotech Values

[floblu14]

MNTA European/U.S. Patent Applications Update for RMF - Plus MNTA Overview of their Patent Estate -

1.TISSUE TARGETING 2013-02-20

Abstract:
Methods and compositions related to targeting agents to tumor tissue are described.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130220&CC=EP&NR=2558506A2&KC=A2

2.POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT AND PREVENTION OF DISORDERS ASSOCIATED WITH PROGENITOR CELL MOBILIZATION 2013-02-20

Abstract:
Polysaccharide preparations lacking substantial anticoagulant activity are provided herein. Methods of making and using such preparations are provided.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130220&CC=EP&NR=2558124A1&KC=A1

3.STRUCTURE ASSESSMENT OF HETEROGENEOUS POLYPEPTIDE MIXTURE
2013-02-14

Abstract:
Methods of analyzing glatiramer acetate (GA) to assess secondary structure, for example, alpha helical content and/or random coil content thereof are provided as are methods for preparing a composition comprising GA and methods for identifying a copolymer as GA.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=2&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130214&CC=US&NR=2013041176A1&KC=A1

4.SELECTION AND USE OF HOST CELLS FOR PRODUCTION OF GLYCOPROTEINS 2013-02-13

Abstract:
A method of making a glycoprotein having a selected glycostructure.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=3&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130213&CC=EP&NR=2555801A1&KC=A1

5.HIGH MANNOSE GLYCANS 2013-02-13

Abstract:
Methods and compositions related to high mannose glycans are described.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=4&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130213&CC=EP&NR=2556163A1&KC=A1

6.EVALUATION OF COPOLYMER DIETHYLAMIDE 2013-01-17

Abstract:
Methods of analyzing glatiramer acetate (GA) or a polymeric precursor thereof are provided. The methods can include determining a level of one or more diethylamide-modified amino acids in a sample comprising GA or a polymeric precursor thereof, and selecting at least a portion of the sample based on the assessment of the one or more diethylamide-modified amino acids in the sample.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130117&CC=WO&NR=2013009885A2&KC=A2

7.STRUCTURE ASSESSMENT OF HETEROGENEOUS POLYPEPTIDE MIXTURES 2013-01-17

Abstract:
The present disclosure provides methods for assessing (e.g., measuring, analyzing, detecting, determining, evaluating, and/or estimating) the secondary structure of Glatiramer Acetate (GA) and, in some instances polymeric precursors of GA. The methods entail assessing the fraction of a sample of GA that is in alpha-helical conformation and/or assessing the fraction of a sample of GA that is in random coil conformation.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130117&CC=WO&NR=2013009864A1&KC=A1

8.CELL CULTURE PROCESS 2013-01-17

Abstract:
Polypeptides having target levels of C-terminal variants are described.

http://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=2&ND=3&adjacent=true&locale=en_EP&FT=D&date=20130117&CC=WO&NR=2013009648A2&KC=A2

PATENTS

We license or own a patent portfolio of over 70 patent families, each of which includes United States patent applications and/or issued patents as well as foreign counterparts to certain United States patents and patent applications. Our patent portfolio includes issued or pending claims covering:

*Methods and technologies for characterizing polysaccharides and other heterogeneous mixtures

*The composition of matter and use of certain heparinases, heparinase variants and other enzymes

*Methods and technologies for synthesis of polysaccharides

*The composition of matter and use of certain novel low molecular weight heparin products, including M402

*Methods to identify, analyze and characterize glycoproteins

*Methods of manufacture of certain polysaccharide, polypeptide and complex protein or biologic products

http://www.momentapharma.com/technology/patents.php